Navigation Links
Empire Genomics Awarded SBIR Phase I Grant from NCI for Companion Diagnostics for Multiple Myeloma
Date:5/28/2013

BUFFALO, N.Y., May 28, 2013 /PRNewswire/ -- Empire Genomics, LLC (www.empiregenomics.com) has been awarded a Phase I SBIR Grant by the National Institute of Health/National Cancer Institute to develop a genomic companion diagnostic test for multiple myeloma (MM). This is the first SBIR grant Empire Genomics has been awarded and it will be funded through October 2013. The Company plans to use these funds to further develop its licensed technology to investigate methods in genomics to predict MM patient response to therapeutic treatments.

"Providing clinical tests that help physicians and patients better understand ideal treatments is critically important to disease management and lowering cost of healthcare," said Anthony Johnson , President & CEO of Empire Genomics. "We are excited to continue working on this assay and with pharmaceutical firms who are developing treatments for MM as we think it will be a useful resource to accelerate clinical trials and ultimately approvals."  

This SBIR funding is further validation of the Empire licensed technology, the need for companion testing in this disease area and fills a void in the early-stage funding required to develop innovative molecular diagnostics.    

About Empire Genomics

Empire Genomics LLC is a firm in the field of molecular genomic testing specializing in oncology. The company offers a wide range of best-in-class services that are used to detect genomic changes. The firm is a leader in the field of personalized medicine and helps clinicians, drug developers and researchers answer key questions in disease diagnosis, disease prognosis, and determining treatment for diseases. 

Contact:

Sonya Stutts

716-856-3873

This press release was issued through eReleases® Press Release Distribution. For more information, visit http://www.ereleases.com.


'/>"/>
SOURCE Empire Genomics, LLC
Copyright©2012 PR Newswire.
All rights reserved

Related biology technology :

1. Research Alert -- Empire Asset Management Co. Initiates Coverage on Exact Sciences (NASDAQ: EXAS)
2. Empire Genomics Licenses Novel DNA Biomarker for Use in Diagnosing and Creating a Companion Diagnostic Test for Neuroendocrine Prostate Cancer
3. Synthetic Genomics Inc. Hires Industry Leader George E. Stagnitti to Head Food and Nutritional Products Development Program
4. New England Biolabs Signs Agreement with Synthetic Genomics Inc. to Launch Gibson Assembly™ Master Mix for Molecular and Synthetic Biology Applications
5. Rubicon Genomics and Agendia Sign Agreement for Use of TransPLEX® Whole Genome RNA Amplification Technology With Symphony™ Cancer Diagnostics
6. Synthetic Genomics Inc. Purchases 81 Acre Site in South California Desert for Scale up and Testing of Innovative Algae Strains
7. Rosetta Genomics Pays Off Secured Loan and Reclaims Unencumbered Rights to All Assets
8. First Plant Genomics Yield Technology Progresses
9. Rosetta Genomics Announces Closing of Public Offering of 5.5 Million Ordinary Shares
10. Rosetta Genomics Receives 2012 North American Entrepreneurial Company of the Year Award by Frost & Sullivan
11. Rosetta Genomics Expands Management Team, Laboratory Capacities and Commercial Operations
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/20/2017)... and PETACH TIKVAH, Israel , ... a leading developer of adult stem cell technologies for neurodegenerative ... Officer, will present at the Alliance for Regenerative Medicine,s (ARM) ... on Thursday, April 27, 2017 at 09:40 EDT in ... Ralph Kern , MD, MHSc, Chief Medical Officer & Chief ...
(Date:4/19/2017)... ... 2017 , ... Optofluidics today announced that it's changing its ... changed focus to making analytical tools for biopharmaceutical quality control. “We are excited ... Robert Hart. Founders Bernardo Cordovez, Robert Hart and David Erickson have steered the ...
(Date:4/19/2017)... April 19, 2017 A new report published by Allied ... 2014-2022 ," the global market was valued at $6,769 million in 2015, and ... from 2016 to 2022. ... Allied Market Research Logo ...      (Logo: http://photos.prnewswire.com/prnh/20140911/647229) The cross-flow ...
(Date:4/18/2017)... ... April 18, 2017 , ... METTLER TOLEDO Process ... concentration levels and vice-versa. , One of the key applications for the measurement ... control or monitoring. The principle of this analytical method is based on pure ...
Breaking Biology Technology:
(Date:4/11/2017)... NXT-ID, Inc. (NASDAQ:   NXTD ) ... appointment of independent Directors Mr. Robin D. Richards ... Directors, furthering the company,s corporate governance and expertise. ... Gino Pereira , Chief Executive ... their guidance and benefiting from their considerable expertise as we ...
(Date:4/4/2017)... --  EyeLock LLC , a leader of iris-based identity ... and Trademark Office (USPTO) has issued U.S. Patent No. ... iris image with a face image acquired in sequence ... th issued patent. "The issuance ... multi-modal biometric capabilities that have recently come to market ...
(Date:3/29/2017)... CHICAGO , March 29, 2017  higi, the ... ecosystem in North America , today ... Partners and the acquisition of EveryMove. The new investment ... extensive set of tools to transform population health activities ... and lifestyle data. higi collects and secures ...
Breaking Biology News(10 mins):